BioSpace News Archive

AliveCor, the leading innovator in FDA-cleared personal electrocardiogram technology, announced the appointment of Patricia Baran as Senior Vice President, Healthcare Americas.

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), reported promising results from preclinical dose range finding studies for Envelta (NES100), Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer.

Alphatec Holdings, Inc., a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced that Pat Miles, Chairman and Chief Executive Officer, and Todd Koning, Chief Financial Officer, will participate in the following investor conferences.

Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $60 million Series A financing round.

Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation cancer immunotherapies, today announced that its co-founder and chief executive officer, Dr. Darren Ji, will participate in a panel discussion about R&D and innovation leading cross-pacific collaboration.

Altesa BioSciences, Inc., an independently operated, for-profit biotechnology company today launched operations to develop and commercialize novel anti-viral drugs against common respiratory viruses like rhinovirus and parainfluenza, and vector-born global viral threats like Dengue fever, Yellow Fever, Zika, and Powassan.

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, announced the withdrawal of the previously announced, proposed public offering.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), announced today that it will be hosting a booth at the upcoming Life Sciences Day on the Hill on February 16, 2022, at the Utah State Capital Building.

CytoReason, a leading developer of computational disease models for efficient drug discovery and development, today announced the extension of its collaboration agreement with Pfizer.

Micro-Tech Endoscopy has introduced the first self-expanding tracheobronchial nitinol y-stent.